NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
11.57
-0.15 (-1.28%)
Nov 13, 2026, 1:09 PM EST - Market open

NovoCure Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
96.7393.55163.77240.82115.33208.8
Short-Term Investments
366.75354.13796.11669.8854.1728.9
Cash & Short-Term Investments
463.48447.67959.87910.62969.43937.7
Cash Growth
-55.15%-53.36%5.41%-6.07%3.38%11.29%
Accounts Receivable
108.2689.4474.2361.2286.2693.57
Other Receivables
51.0723.053.335.2612.398.42
Receivables
159.33112.4877.5566.4898.65101.99
Inventory
40.6141.1135.0938.1529.3824.43
Prepaid Expenses
-9.717.326.856.424.76
Restricted Cash
10.119.842.331.740.510.81
Other Current Assets
-25.9124.4110.567.153.84
Total Current Assets
673.52646.731,1071,0341,1121,074
Property, Plant & Equipment
144.09147119.5997.768.9653.88
Other Long-Term Assets
11.110.614.6214.0211.1612.09
Total Assets
828.71804.331,2411,1461,1921,139

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
145.92122.23105.0994.3985.272.6
Accrued Expenses
-73.0670.9860.1849.4445.39
Current Portion of Long-Term Debt
25-558.16---
Current Portion of Leases
-11.667.91---
Current Unearned Revenue
-15.9514.2316.2218.0317.76
Other Current Liabilities
99.740.330.038.326.116.85
Total Current Liabilities
270.66223.23756.39179.12158.78142.6
Long-Term Debt
171.34195.0597.3568.82565.58562.23
Long-Term Leases
35.2241.6519.9727.4218.7613
Long-Term Unearned Revenue
----2.886.48
Pension & Post-Retirement Benefits
0.883.946.948.264.44.54
Other Long-Term Liabilities
---0.020.080.15
Total Liabilities
478.1463.86880.61783.63750.48729

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Additional Paid-In Capital
1,7401,6341,5201,3531,2221,100
Retained Earnings
-1,388-1,290-1,154-985.5-778.46-685.93
Comprehensive Income & Other
-1.59-3.44-5.5-5.47-2.43-3.17
Shareholders' Equity
350.61340.47360.18362.5441.17410.49
Total Liabilities & Equity
828.71804.331,2411,1461,1921,139

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
231.55248.35683.34596.24584.34575.23
Net Cash (Debt)
231.93199.32276.53314.37385.08362.48
Net Cash Growth
-1.54%-27.92%-12.04%-18.36%6.24%-9.00%
Net Cash Per Share
2.021.792.562.953.683.50
Filing Date Shares Outstanding
116.92113.79109.92107.09105.46104.42
Total Common Shares Outstanding
112.49112.49108.52107.08105.05103.97
Working Capital
402.86423.5350.18855.29952.75930.92
Book Value Per Share
3.123.033.323.394.203.95
Tangible Book Value
350.61340.47360.18362.5441.17410.49
Tangible Book Value Per Share
3.123.033.323.394.203.95
Land
-34.9534.5324.715.9911.16
Machinery
-70.863.3143.0530.9426.56
Leasehold Improvements
-13.7312.1311.79.357.08
SEC Filings: 10-K · 10-Q